1.06
price down icon5.36%   -0.06
after-market Handel nachbörslich: 1.09 0.03 +2.83%
loading

Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
1.28%
34.67
34.23 31.43 31.76 29.61
Cost Of Revenue
14.58%
8.444
9.885 18.21 20.16 16.85
Gross Profit
7.71%
26.23
24.35 13.23 11.60 12.76
Operating Expenses
10.25%
31.02
34.57 38.16 54.01 45.82
Benefits Costs and Expenses
10.25%
31.02
34.57 38.16 74.17 62.68
Costs And Expenses
10.25%
31.02
34.57 38.16 74.17 62.68
Operating Income/Loss
53.05%
-4.798
-10.22 -24.93 -42.40 -33.06
Income/Loss From Continuing Operations Before Tax
1,188%
3.646
-0.335 -6.721 -42.06 -32.77
Income/Loss From Continuing Operations After Tax
70.53%
-3.16
-10.72 -25.01 -42.06 -32.77
Net Income/Loss
70.53%
-3.16
-10.72 -25.01 -42.06 -32.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,346%
151.20
4.388 144.99 119.72 119.25
Diluted Average Shares
3,346%
151.20
4.388 144.99 119.72 119.25
Basic Earnings Per Share
60.00%
-0.02
-0.05 -0.17 -0.35 -0.27
Diluted Earnings Per Share
60.00%
-0.02
-0.05 -0.17 -0.35 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):